Antibody tests being rolled out can broadly survey who in cities like New York City (above) cleared an infection with the new coronavirus without knowing it.
By Gretchen VogelHow many COVID-19 cases have gone undetected? And are those who had mild cases of the disease—perhaps so mild they dismissed it as a cold or allergies—immune to new infections?
If so, they could slow the spread of the burgeoning pandemic.Answering those questions is crucial to managing the pandemic and forecasting its course.
But the answers won’t come from the RNA-based diagnostic tests now being given by the tens of thousands. They look for the presence of viral genes in a nose or throat swab, a sign of an active infection.